TRPM3 and myalgic encephalomeyelitis/chronic fatigue syndrome: Furthermore, patch-clamp experiments in NK cells from individuals with ME/CFS revealed significant reduction in TRPM3 ion channel activity compared to healthy controls (HC) after modulation with various agonists, as well as a significant increase in resistance to the TRPM3 antagonist agent (29, 37).